Sign in
Stories
BioNTech Investors' Lawsuit Alert
Share
Amylyx Pharmaceuticals Faces Lawsuit
Assertio Faces Lawsuit Amid Stock Declin...
Assertio Holdings Faces Investor Lawsuit
Altimmune Faces Investor Investigation
BioNTech Investors Alert: Lawsuit Potent...
Biopharma Lawsuit Impact: Ventyx Crisis
Overview
API
Rosen Law Firm alerts BioNTech SE investors about the lead plaintiff deadline on March 12, 2024, citing alleged misleading statements by BioNTech on its COVID-19 vaccine, potentially leading to a class action lawsuit.
Ask a question
Could this event influence transparency and disclosure practices in the biopharmaceutical industry?
How might this lawsuit impact BioNTech's reputation and future vaccine developments?
What measures can investors take to determine their eligibility for compensation?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage